Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ASAQNASDAQ:DALSNASDAQ:FHLTNASDAQ:SRSANASDAQ:TCAC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASAQAtlantic Avenue Acquisition$10.03$10.02$9.78▼$10.51$250.75M-0.0255,003 shs141,340 shsDALSDA32 Life Science Tech Acquisition$10.32+0.2%$10.29$9.68▼$11.22$264.71MN/A88,802 shs2,200 shsFHLTFuture Health ESG$12.70-0.9%$11.12$9.97▼$15.05$75.44M-0.058,288 shs20,648 shsSRSASarissa Capital Acquisition$10.05$10.03$9.72▼$10.80$251.25M-0.0554,101 shs7,304 shsTCACTuatara Capital Acquisition$8.55$9.15$7.79▼$9.99$213.75M-0.0558,561 shs70,881 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASAQAtlantic Avenue Acquisition0.00%0.00%0.00%0.00%0.00%DALSDA32 Life Science Tech Acquisition0.00%0.00%0.00%0.00%+1.57%FHLTFuture Health ESG+4.12%+3.36%+18.80%+20.03%+26.18%SRSASarissa Capital Acquisition0.00%0.00%0.00%0.00%0.00%TCACTuatara Capital Acquisition0.00%0.00%0.00%0.00%0.00%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASAQAtlantic Avenue AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ADALSDA32 Life Science Tech AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AFHLTFuture Health ESGN/AN/AN/AN/AN/AN/AN/AN/ASRSASarissa Capital AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ATCACTuatara Capital AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASAQAtlantic Avenue AcquisitionN/AN/AN/AN/ADALSDA32 Life Science Tech AcquisitionN/AN/AN/AN/AFHLTFuture Health ESGN/AN/AN/AN/ASRSASarissa Capital AcquisitionN/AN/AN/AN/ATCACTuatara Capital AcquisitionN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASAQAtlantic Avenue AcquisitionN/AN/A$0.38 per share26.15($0.43) per shareN/ADALSDA32 Life Science Tech AcquisitionN/AN/A$0.02 per share441.92($0.18) per shareN/AFHLTFuture Health ESGN/AN/AN/AN/A($1.56) per shareN/ASRSASarissa Capital AcquisitionN/AN/A$0.78 per share12.95($0.66) per shareN/ATCACTuatara Capital AcquisitionN/AN/A$0.28 per share30.33($0.69) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASAQAtlantic Avenue Acquisition$9.59MN/A0.00∞N/AN/A-168.93%5.46%N/ADALSDA32 Life Science Tech Acquisition$600KN/A0.00∞N/AN/A-37.55%0.85%N/AFHLTFuture Health ESG-$50KN/A0.00∞N/AN/A-9.79%-0.28%N/ASRSASarissa Capital Acquisition$19.40MN/A0.00∞N/AN/A-99.58%6.31%N/ATCACTuatara Capital Acquisition$7.71MN/A0.00∞N/AN/A-123.64%6.48%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASAQAtlantic Avenue AcquisitionN/AN/AN/AN/AN/ADALSDA32 Life Science Tech AcquisitionN/AN/AN/AN/AN/AFHLTFuture Health ESGN/AN/AN/AN/AN/ASRSASarissa Capital AcquisitionN/AN/AN/AN/AN/ATCACTuatara Capital AcquisitionN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASAQAtlantic Avenue AcquisitionN/A0.290.29DALSDA32 Life Science Tech AcquisitionN/A0.360.36FHLTFuture Health ESGN/A0.020.02SRSASarissa Capital AcquisitionN/A9.169.16TCACTuatara Capital AcquisitionN/A0.280.28OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASAQAtlantic Avenue Acquisition92.47%DALSDA32 Life Science Tech Acquisition66.05%FHLTFuture Health ESG24.57%SRSASarissa Capital Acquisition69.15%TCACTuatara Capital Acquisition75.00%Insider OwnershipCompanyInsider OwnershipASAQAtlantic Avenue Acquisition16.00%DALSDA32 Life Science Tech AcquisitionN/AFHLTFuture Health ESG57.20%SRSASarissa Capital AcquisitionN/ATCACTuatara Capital AcquisitionN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableASAQAtlantic Avenue Acquisition525.00 million21.00 millionNot OptionableDALSDA32 Life Science Tech Acquisition2,021N/AN/ANot OptionableFHLTFuture Health ESG2,0215.94 million2.54 millionNot OptionableSRSASarissa Capital Acquisition625.00 millionN/ANot OptionableTCACTuatara Capital Acquisition325.00 millionN/ANot OptionableSRSA, ASAQ, FHLT, DALS, and TCAC HeadlinesSourceHeadlineCannabis marketing platform SpringBig secures approval to go publicfinance.yahoo.com - July 11 at 8:16 AMMedia Sentiment Over TimeCompany DescriptionsAtlantic Avenue AcquisitionNYSE:ASAQAtlantic Avenue Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Stamford, Connecticut.DA32 Life Science Tech AcquisitionNASDAQ:DALSDA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.Future Health ESGNASDAQ:FHLTFuture Health ESG Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to pursue an initial business combination opportunity in the smart health technology sector. Future Health ESG Corp. was incorporated in 2021 and is based in Dover, Delaware.Sarissa Capital AcquisitionNASDAQ:SRSASarissa Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry. Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.Tuatara Capital AcquisitionNASDAQ:TCACTuatara Capital Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in cannabis industry. Tuatara Capital Acquisition Corporation was incorporated in 2020 and is based in New York, New York. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.